140 related articles for article (PubMed ID: 10470289)
1. Indomethacin suppresses the growth of colon 26, Meth-A and FM3A tumors in mice by reducing the prostaglandin E2 content and telomerase activity in tumor tissues.
Ogino M; Hisatomi H; Murata M; Hanazono M
Jpn J Cancer Res; 1999 Jul; 90(7):758-64. PubMed ID: 10470289
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of indomethacin as an antitumor agent in Colon 26-bearing conventional and nude mice, and telomerase activity in the tumors.
Ogino M; Hisatomi H; Hanazono M
Exp Anim; 1999 Jan; 48(1):15-21. PubMed ID: 10067201
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin and telomerase activity in tumor growth retardation.
Lönnroth C; Andersson M; Lundholm K
Int J Oncol; 2001 May; 18(5):929-37. PubMed ID: 11295037
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice.
Santander S; Cebrián C; Esquivias P; Conde B; Esteva F; Jiménez P; Ortego J; Lanas A; Piazuelo E
Int J Oncol; 2012 Feb; 40(2):527-34. PubMed ID: 21971589
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo.
Eli Y; Przedecki F; Levin G; Kariv N; Raz A
Biochem Pharmacol; 2001 Mar; 61(5):565-71. PubMed ID: 11239499
[TBL] [Abstract][Full Text] [Related]
6. A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity.
Gowan SM; Harrison JR; Patterson L; Valenti M; Read MA; Neidle S; Kelland LR
Mol Pharmacol; 2002 May; 61(5):1154-62. PubMed ID: 11961134
[TBL] [Abstract][Full Text] [Related]
7. Decrease in nucleophosmin/B23 mRNA and telomerase activity during indomethacin-induced apoptosis of gastric KATO-III cancer cells.
You BJ; Huang IJ; Liu WH; Hung YB; Chang JH; Yung BY
Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):683-90. PubMed ID: 10619186
[TBL] [Abstract][Full Text] [Related]
8. Effect of combined administration of a synthetic low-toxicity lipid A derivative, DT-5461a, and indomethacin in various experimental tumor models of colon 26 carcinoma in mice.
Jimbo T; Akimoto T; Tohgo A
Cancer Immunol Immunother; 1995 Jan; 40(1):10-6. PubMed ID: 7828163
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of acemetacin in mice bearing colon 26 carcinoma: a preliminary report.
Kisara S; Maekawa I; Sasaki K; Suzuki N; Hayashi A; Furusawa S; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1993 Aug; 81(2):247-50. PubMed ID: 8210703
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of murine tumor growth and prostaglandin synthesis by indomethacin.
Fulton AM; Levy JG
Int J Cancer; 1980 Nov; 26(5):669-73. PubMed ID: 6453846
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of transplantable murine colon adenocarcinoma 38 by indomethacin.
Sato M; Narisawa T; Sano M; Takahashi T; Goto A
J Cancer Res Clin Oncol; 1983; 106(1):21-6. PubMed ID: 6885896
[TBL] [Abstract][Full Text] [Related]
12. Influence of dietary fat and indomethacin on the growth of transplantable mammary tumors in rats.
Kollmorgen GM; King MM; Kosanke SD; Do C
Cancer Res; 1983 Oct; 43(10):4714-9. PubMed ID: 6576855
[TBL] [Abstract][Full Text] [Related]
13. Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.
Pozzi A; Yan X; Macias-Perez I; Wei S; Hata AN; Breyer RM; Morrow JD; Capdevila JH
J Biol Chem; 2004 Jul; 279(28):29797-804. PubMed ID: 15123663
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of indomethacin in mice bearing advanced colon 26 carcinoma compared with those with early transplants.
Tanaka Y; Tanaka T; Ishitsuka H
Cancer Res; 1989 Nov; 49(21):5935-9. PubMed ID: 2790809
[TBL] [Abstract][Full Text] [Related]
15. Differential induction of prostaglandin E2-dependent and -independent immune suppressor cells by tumor-derived GM-CSF and M-CSF.
Oghiso Y; Yamada Y; Ando K; Ishihara H; Shibata Y
J Leukoc Biol; 1993 Jan; 53(1):86-92. PubMed ID: 7678847
[TBL] [Abstract][Full Text] [Related]
16. 16,16-Dimethyl prostaglandin E2 suppresses the increases in the proliferative activity of rat colonic epithelium induced by indomethacin and aspirin.
DeRubertis FR; Craven PA; Saito R
Gastroenterology; 1985 Nov; 89(5):1054-63. PubMed ID: 4043664
[TBL] [Abstract][Full Text] [Related]
17. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
[TBL] [Abstract][Full Text] [Related]
18. The anticancer effect of phospho-tyrosol-indomethacin (MPI-621), a novel phosphoderivative of indomethacin: in vitro and in vivo studies.
Zhou D; Papayannis I; Mackenzie GG; Alston N; Ouyang N; Huang L; Nie T; Wong CC; Rigas B
Carcinogenesis; 2013 Apr; 34(4):943-51. PubMed ID: 23338686
[TBL] [Abstract][Full Text] [Related]
19. [Anti-cancer treatment with prostaglandin synthetase inhibitor in animal models].
Narisawa T; Takahashi M; Masuda T; Nagasawa O; Ogata N; Niwa M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1329-35. PubMed ID: 3089171
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of the growth of a murine transplantable tumor, colon 26, by the prostaglandin synthetase inhibitor, indomethacin].
Takahashi M; Narisawa T; Masuda T; Nagasawa O; Suzuki K; Yoshioka H; Koyama H
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2334-40. PubMed ID: 3111384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
